Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference newsletter


  Influenza

  Free Subscription


14.09.2020

3 Am J Med
4 Antiviral Res
15 BMJ
3 Epidemiol Infect
7 J Clin Microbiol
1 J Immunol
1 J Infect
9 J Infect Dis
4 J Virol
3 J Virol Methods
8 Lancet
1 Lancet Child Adolesc Health
1 Lancet HIV
15 Lancet Infect Dis
5 Lancet Oncol
5 Lancet Public Health
3 Lancet Respir Med
5 N Engl J Med
2 Pediatrics
1 Proc Natl Acad Sci U S A
5 Vaccine
4 Virology
9 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. YETMAR ZA, Issa M, Munawar S, Burton MC, et al
    Inpatient Care of Patients with COVID-19: A Guide for Hospitalists.
    Am J Med. 2020;133:1019-1024.
    PubMed         Abstract available

  2. SEVERIN R, Arena R, Lavie CJ, Bond S, et al
    Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation.
    Am J Med. 2020;133:1025-1032.
    PubMed         Abstract available

  3. SHIH RD, Johnson HM, Maki DG, Hennekens CH, et al
    Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
    Am J Med. 2020;133:1007-1008.
    PubMed        


    Antiviral Res

  4. CONZELMANN C, Gilg A, Gross R, Schutz D, et al
    An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection.
    Antiviral Res. 2020 Jul 29:104882. doi: 10.1016/j.antiviral.2020.104882.
    PubMed         Abstract available

  5. GALLIAN P, Pastorino B, Morel P, Chiaroni J, et al
    Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.
    Antiviral Res. 2020 Jul 14:104880. doi: 10.1016/j.antiviral.2020.104880.
    PubMed         Abstract available

  6. PIZZORNO A, Padey B, Dubois J, Julien T, et al
    In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
    Antiviral Res. 2020 Jul 14:104878. doi: 10.1016/j.antiviral.2020.104878.
    PubMed         Abstract available

  7. KIM SY, Jin W, Sood A, Montgomery DW, et al
    Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
    Antiviral Res. 2020 Jul 9:104873. doi: 10.1016/j.antiviral.2020.104873.
    PubMed         Abstract available


    BMJ

  8. ALLOTEY J, Stallings E, Bonet M, Yap M, et al
    Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.
    BMJ. 2020;370:m3320.
    PubMed         Abstract available

  9. PLOEM C, Suurmond J
    Registering ethnicity for covid-19 research: is the law an obstacle?
    BMJ. 2020;370:m3367.
    PubMed        

  10. AHMED I
    Covid-19: prioritising rehabilitation when mortality figures dominate the headlines.
    BMJ. 2020;370:m3381.
    PubMed        

  11. SLINGO M
    Doctors' pay rise: don't be deceived, it's not for covid-19.
    BMJ. 2020;370:m3335.
    PubMed        

  12. BURMAN R, Cairns R, Canestrini S, Elias R, et al
    Making ordinary decisions in extraordinary times.
    BMJ. 2020;370:m3268.
    PubMed        

  13. SUNDAR S
    Covid-19 risk assessment: a futile metaphorical strip search.
    BMJ. 2020;370:m3251.
    PubMed        

  14. JOHNSON RM, Doshi P, Healy D
    Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?
    BMJ. 2020;370:m3260.
    PubMed        

  15. CADDY S
    Russian SARS-CoV-2 vaccine.
    BMJ. 2020;370:m3270.
    PubMed        

  16. BRIERLEY J
    Covid-19 inquiry: ducking the issue, ducks in a row, and pandemic anatidaephobia.
    BMJ. 2020;370:m3241.
    PubMed        

  17. MURRAY J
    Has Sweden's controversial covid-19 strategy been successful or not?
    BMJ. 2020;370:m3255.
    PubMed        

  18. KUMAR A, Pareek V, Narayan RK, Kant K, et al
    Covid-19 in India: Dharavi's success story.
    BMJ. 2020;370:m3264.
    PubMed        

  19. YAMEY G, Walensky RP
    Covid-19: re-opening universities is high risk.
    BMJ. 2020;370:m3365.
    PubMed        

  20. KNIGHT M, Morris RK, Furniss J, Chappell LC, et al
    Include pregnant women in research-particularly covid-19 research.
    BMJ. 2020;370:m3305.
    PubMed        

  21. JONES NR, Qureshi ZU, Temple RJ, Larwood JPJ, et al
    Two metres or one: what is the evidence for physical distancing in covid-19?
    BMJ. 2020;370:m3223.
    PubMed        

  22. HARVEY A
    Adapting to the unexpected.
    BMJ. 2020;370:m2944.
    PubMed        


    Epidemiol Infect

  23. PIKOVSKI A, Bentele K
    Pooling of coronavirus tests under unknown prevalence.
    Epidemiol Infect. 2020;148:e183.
    PubMed         Abstract available

  24. ROUEN A, Adda J, Roy O, Rogers E, et al
    COVID-19: relationship between atmospheric temperature and daily new cases growth rate.
    Epidemiol Infect. 2020;148:e184.
    PubMed         Abstract available

  25. DARCIS G, Vaira D, Moutschen M
    Impact of coronavirus pandemic and containment measures on HIV diagnosis.
    Epidemiol Infect. 2020;148:e185.
    PubMed         Abstract available


    J Clin Microbiol

  26. BONELLI F, Sarasini A, Zierold C, Calleri M, et al
    Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

  27. SZYMCZAK WA, Goldstein DY, Orner EP, Fecher RA, et al
    Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

  28. FUNG B, Gopez A, Servellita V, Arevalo S, et al
    Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

  29. NAGURA-IKEDA M, Imai K, Tabata S, Miyoshi K, et al
    Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

  30. SMITH E, Zhen W, Manji R, Schron D, et al
    Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection.
    J Clin Microbiol. 2020;58.
    PubMed         Abstract available

  31. GREENE DN, Dickerson JA, Greninger AL, Schmidt RL, et al
    When To Retest: an Examination of Repeat COVID-19 PCR Patterns in an Ambulatory Population.
    J Clin Microbiol. 2020;58.
    PubMed        

  32. CHOW EPF, Bradshaw CS, Williamson DA, Hall S, et al
    Changing from clinician-collected to self-collected throat swabs for oropharyngeal gonorrhoea and chlamydia screening among men who have sex with men.
    J Clin Microbiol. 2020 Jul 1. pii: JCM.01215-20. doi: 10.1128/JCM.01215.
    PubMed         Abstract available


    J Immunol

  33. FRANCO R, Rivas-Santisteban R, Serrano-Marin J, Rodriguez-Perez AI, et al
    SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
    J Immunol. 2020;205:1198-1206.
    PubMed         Abstract available


    J Infect

  34. MIRZA FN, Malik AA, Couzens C, Omer SB, et al
    Influenza-Negative Influenza-Like Illness (fnILI) Z-Score as a Proxy for Incidence and Mortality of COVID-19.
    J Infect. 2020 Sep 1. pii: S0163-4453(20)30581.
    PubMed         Abstract available


    J Infect Dis

  35. HADLER JL
    Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere?
    J Infect Dis. 2020 Sep 7. pii: 5902575. doi: 10.1093.
    PubMed        

  36. HELLEBERG M, Niemann CU, Moestrup KS, Kirk O, et al
    Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
    J Infect Dis. 2020;222:1103-1107.
    PubMed         Abstract available

  37. GUBAREVA LV, Fry AM
    Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
    J Infect Dis. 2020;221:337-339.
    PubMed        

  38. MONTO AS
    Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases.
    J Infect Dis. 2020;221:340-342.
    PubMed        

  39. TENG MN, Mejias A, Ramilo O, Peeples ME, et al
    Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
    PubMed        

  40. WONG MCS, Huang J, Teoh JYC, Wong SH, et al
    Identifying a Capability Framework That Could Mitigate the Coronavirus Disease 2019 Pandemic in a Global Health Community.
    J Infect Dis. 2020;222:880-881.
    PubMed        

  41. LEI H, Xu M, Wang X, Xie Y, et al
    Non-pharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China.
    J Infect Dis. 2020 Sep 8. pii: 5902938. doi: 10.1093.
    PubMed         Abstract available

  42. YAMAGISHI T, Ohnishi M, Matsunaga N, Kakimoto K, et al
    Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
    J Infect Dis. 2020;222:1098-1102.
    PubMed         Abstract available

  43. SHOOK-SA BE, Boyce RM, Aiello AE
    Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
    J Infect Dis. 2020;222:1086-1089.
    PubMed         Abstract available


    J Virol

  44. STEINER F, Pavlovic J
    Subcellular localization of MxB determines its antiviral potential against influenza A virus.
    J Virol. 2020 Sep 9. pii: JVI.00125-20. doi: 10.1128/JVI.00125.
    PubMed         Abstract available

  45. KIRKPATRICK E, Henry C, McMahon M, Jiang K, et al
    Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity.
    J Virol. 2020 Sep 9. pii: JVI.01185-20. doi: 10.1128/JVI.01185.
    PubMed         Abstract available

  46. EL-SHESHENY R, Franks J, Turner J, Seiler P, et al
    Continued Evolution of H5Nx Avian Influenza Viruses in Bangladeshi Live Poultry Markets: Pathogenic Potential in Poultry and Mammalian Models.
    J Virol. 2020 Sep 9. pii: JVI.01141-20. doi: 10.1128/JVI.01141.
    PubMed         Abstract available

  47. SONG J, Sun H, Sun H, Jiang Z, et al
    Swine microRNAs ssc-miR-221-3p and ssc-miR-222 restrict the cross-species infection of avian influenza virus.
    J Virol. 2020 Sep 9. pii: JVI.01700-20. doi: 10.1128/JVI.01700.
    PubMed         Abstract available


    J Virol Methods

  48. GOMEZ J, Melon S, Boga JA, Alvarez-Arguelles ME, et al
    Capillary electrophoresis of PCR fragments with 5 -labelled primers for testing the SARS-Cov-2.
    J Virol Methods. 2020;284:113937.
    PubMed         Abstract available

  49. GOLDENBERGER D, Leuzinger K, Sogaard KK, Gosert R, et al
    Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay.
    J Virol Methods. 2020;284:113925.
    PubMed         Abstract available

  50. HIROTSU Y, Mochizuki H, Omata M
    Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay.
    J Virol Methods. 2020;284:113926.
    PubMed         Abstract available


    Lancet

  51. MAUVAIS-JARVIS F, Bairey Merz N, Barnes PJ, Brinton RD, et al
    Sex and gender: modifiers of health, disease, and medicine.
    Lancet. 2020;396:565-582.
    PubMed         Abstract available

  52. THE LANCET
    COVID-19: a new lens for non-communicable diseases.
    Lancet. 2020;396:649.
    PubMed        

  53. ANDERSON RM, Hollingsworth TD, Baggaley RF, Maddren R, et al
    COVID-19 spread in the UK: the end of the beginning?
    Lancet. 2020 Aug 3. pii: S0140-6736(20)31689.
    PubMed        

  54. THE LANCET
    Research and higher education in the time of COVID-19.
    Lancet. 2020;396:583.
    PubMed        

  55. VERKUIL LD, Liu GT, Brahma VL, Avery RA, et al
    Pseudotumor cerebri syndrome associated with MIS-C: a case report.
    Lancet. 2020;396:532.
    PubMed        

  56. BRAUN F, Lutgehetmann M, Pfefferle S, Wong MN, et al
    SARS-CoV-2 renal tropism associates with acute kidney injury.
    Lancet. 2020 Aug 14. pii: S0140-6736(20)31759.
    PubMed        

  57. YOUNG BE, Fong SW, Chan YH, Mak TM, et al
    Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
    Lancet. 2020 Aug 18. pii: S0140-6736(20)31757.
    PubMed         Abstract available

  58. THE LANCET
    Trump versus Biden: a fight for the health of a nation.
    Lancet. 2020;396:513.
    PubMed        


    Lancet Child Adolesc Health

  59. THE LANCET CHILD ADOLESCENT HE
    Our first footprints.
    Lancet Child Adolesc Health. 2020;4:641.
    PubMed        


    Lancet HIV

  60. LESOSKY M, Myer L
    Modelling the impact of COVID-19 on HIV.
    Lancet HIV. 2020 Aug 6. pii: S2352-3018(20)30228.
    PubMed        


    Lancet Infect Dis

  61. BENEZIT F, Le Turnier P, Declerck C, Paille C, et al
    Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30297.
    PubMed        

  62. BURKI T
    The origin of SARS-CoV-2.
    Lancet Infect Dis. 2020;20:1018-1019.
    PubMed        

  63. THE LANCET INFECTIOUS DISEASES
    Air travel in the time of COVID-19.
    Lancet Infect Dis. 2020;20:993.
    PubMed        

  64. HEYWOOD AE, Macintyre CR
    Elimination of COVID-19: what would it look like and is it possible?
    Lancet Infect Dis. 2020 Aug 6. pii: S1473-3099(20)30633.
    PubMed        

  65. KIRBY T
    Annelies Wilder-Smith.
    Lancet Infect Dis. 2020;20:907.
    PubMed        

  66. BARBER S
    Death by racism.
    Lancet Infect Dis. 2020;20:903.
    PubMed        

  67. PEELING RW, Wedderburn CJ, Garcia PJ, Boeras D, et al
    Serology testing in the COVID-19 pandemic response.
    Lancet Infect Dis. 2020 Jul 17. pii: S1473-3099(20)30517.
    PubMed         Abstract available

  68. MEI Q, Li J, Du R, Yuan X, et al
    Assessment of patients who tested positive for COVID-19 after recovery.
    Lancet Infect Dis. 2020 Jul 6. pii: S1473-3099(20)30433.
    PubMed        

  69. TABATA S, Imai K, Kawano S, Ikeda M, et al
    Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30482.
    PubMed         Abstract available

  70. XYDAKIS MS, Dehgani-Mobaraki P, Holbrook EH, Geisthoff UW, et al
    Smell and taste dysfunction in patients with COVID-19.
    Lancet Infect Dis. 2020 Apr 15. pii: S1473-3099(20)30293.
    PubMed        

  71. DE LUSIGNAN S, Dorward J, Correa A, Jones N, et al
    Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.
    Lancet Infect Dis. 2020 May 15. pii: S1473-3099(20)30371.
    PubMed         Abstract available

  72. PEAK CM, Kahn R, Grad YH, Childs LM, et al
    Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.
    Lancet Infect Dis. 2020 May 20. pii: S1473-3099(20)30361.
    PubMed         Abstract available


  73. Global outbreak research: harmony not hegemony.
    Lancet Infect Dis. 2020;20:770-772.
    PubMed        

  74. HUNG IF, Cheng VC, Li X, Tam AR, et al
    SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
    Lancet Infect Dis. 2020 Jun 12. pii: S1473-3099(20)30364.
    PubMed         Abstract available

  75. HEATH PT, Le Doare K, Khalil A
    Inclusion of pregnant women in COVID-19 vaccine development.
    Lancet Infect Dis. 2020 Aug 11. pii: S1473-3099(20)30638.
    PubMed        


    Lancet Oncol

  76. ZHANG G, An Y, Zhang L, Xie L, et al
    Risk factors for in-hospital mortality in patients with cancer and COVID-19.
    Lancet Oncol. 2020;21:e407.
    PubMed        

  77. GUO K, Sun L, Yuan L, Wasan HS, et al
    Risk factors for in-hospital mortality in patients with cancer and COVID-19.
    Lancet Oncol. 2020;21:e406.
    PubMed        

  78. YANG K, Sheng Y, Wu B, Wu G, et al
    Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.
    Lancet Oncol. 2020;21:e408.
    PubMed        

  79. GALLOWAY TJ, Kowalski LP, Matos LL, Junior GC, et al
    Head and neck surgery recommendations during the COVID-19 pandemic.
    Lancet Oncol. 2020;21:e416.
    PubMed        

  80. MEHANNA H
    Head and neck surgery recommendations during the COVID-19 pandemic - Author's reply.
    Lancet Oncol. 2020;21:e417.
    PubMed        


    Lancet Public Health

  81. NGUYEN LH, Drew DA, Graham MS, Joshi AD, et al
    Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study.
    Lancet Public Health. 2020 Jul 30. pii: S2468-2667(20)30164.
    PubMed         Abstract available

  82. MURRAY CJL, Alamro NMS, Hwang H, Lee U, et al
    Digital public health and COVID-19.
    Lancet Public Health. 2020 Aug 10. pii: S2468-2667(20)30187.
    PubMed        

  83. PELL R, Fryer E, Manek S, Winter L, et al
    Coronial autopsies identify the indirect effects of COVID-19.
    Lancet Public Health. 2020 Aug 10. pii: S2468-2667(20)30180.
    PubMed        

  84. THE LANCET PUBLIC HEALTH
    Will the COVID-19 pandemic threaten the SDGs?
    Lancet Public Health. 2020;5:e460.
    PubMed        

  85. SULLIVAN LM, Velez AA, Galea S
    Graduate public health education in the post-COVID-19 era.
    Lancet Public Health. 2020;5:e473.
    PubMed        


    Lancet Respir Med

  86. PEELING RW, Olliaro PL
    The time to do serosurveys for COVID-19 is now.
    Lancet Respir Med. 2020 Jul 24. pii: S2213-2600(20)30313.
    PubMed        

  87. BECHER T, Frerichs I
    Mortality in COVID-19 is not merely a question of resource availability.
    Lancet Respir Med. 2020 Jul 28. pii: S2213-2600(20)30312.
    PubMed        

  88. THE LANCET RESPIRATORY MEDICIN
    The EVALI outbreak and vaping in the COVID-19 era.
    Lancet Respir Med. 2020 Aug 14. pii: S2213-2600(20)30360.
    PubMed        


    N Engl J Med

  89. GILLENWATER S, Rahaghi F, Hadeh A
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    PubMed        

  90. MCMAHON JH, Udy A, Peleg AY
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    PubMed        

  91. MCCAW ZR, Kim DH, Wei LJ
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    PubMed        

  92. OLALLA J
    Remdesivir for the Treatment of Covid-19 - Preliminary Report.
    N Engl J Med. 2020;383.
    PubMed        

  93. BEIGEL JH, Tomashek KM, Dodd LE
    Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
    N Engl J Med. 2020;383.
    PubMed        


    Pediatrics


  94. Recommendations for Prevention and Control of Influenza in Children, 2020-2021.
    Pediatrics. 2020 Sep 8. pii: peds.2020-024588. doi: 10.1542/peds.2020-024588.
    PubMed         Abstract available

  95. DREYER BP
    Let Us Be Vigilant: COVID-19 Is Poised to Obliterate Gains in Healthy Child Development Globally.
    Pediatrics. 2020;146.
    PubMed        


    Proc Natl Acad Sci U S A


  96. Correction to Supporting Information for Sun et al., Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
    Proc Natl Acad Sci U S A. 2020 Sep 8. pii: 2017619117.
    PubMed        


    Vaccine

  97. O'LEARY ST, Pyrzanowski J, Brewer SE, Sevick C, et al
    Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30658.
    PubMed         Abstract available

  98. MURALIDHARAN A, Russell MS, Larocque L, Gravel C, et al
    Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30753.
    PubMed         Abstract available

  99. MANARA C, Brazzoli M, Piccioli D, Taccone M, et al
    Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30479.
    PubMed         Abstract available

  100. OTIENO NA, Nyawanda B, Otiato F, Adero M, et al
    Knowledge and attitudes towards influenza and influenza vaccination among pregnant women in Kenya.
    Vaccine. 2020 Sep 3. pii: S0264-410X(20)31046.
    PubMed         Abstract available

  101. LAU LHW, Lee SS, Wong NS
    The continuum of influenza vaccine hesitancy among nursing professionals in Hong Kong.
    Vaccine. 2020 Sep 2. pii: S0264-410X(20)31079.
    PubMed         Abstract available


    Virology

  102. MOHTADI N, Ghaysouri A, Shirazi S, Sara Ansari, et al
    Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
    Virology. 2020;548:1-5.
    PubMed         Abstract available

  103. MCALLISTER CS, Ansaldi D, Growcott EJ, Zhong Y, et al
    Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling.
    Virology. 2020;540:195-206.
    PubMed         Abstract available

  104. LUDEKE B, Fearns R
    The respiratory syncytial virus polymerase can perform RNA synthesis with modified primers and nucleotide analogs.
    Virology. 2020;540:66-74.
    PubMed         Abstract available

  105. KIM KH, Jung YJ, Lee Y, Park BR, et al
    Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Virology. 2020;550:51-60.
    PubMed         Abstract available


    Virus Res

  106. POST A, Dullaart RPF, Bakker SJL
    Sodium status and kidney involvement during COVID-19 infection.
    Virus Res. 2020;286:198034.
    PubMed         Abstract available

  107. LI J, Gong X, Wang Z, Chen R, et al
    Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China.
    Virus Res. 2020;286:198043.
    PubMed         Abstract available

  108. LI J, Wei X, Tian W, Zou J, et al
    Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.
    Virus Res. 2020;286:198047.
    PubMed        

  109. BEHLOUL N, Baha S, Shi R, Meng J, et al
    Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Virus Res. 2020;286:198058.
    PubMed         Abstract available

  110. ROMEO A, Iacovelli F, Falconi M
    Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Virus Res. 2020;286:198068.
    PubMed         Abstract available

  111. MAGRO G
    COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
    Virus Res. 2020;286:198070.
    PubMed         Abstract available

  112. LI C, Wang L, Ren L
    Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
    Virus Res. 2020;286:198073.
    PubMed         Abstract available

  113. AHLAWAT S, Asha, Sharma KK
    Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
    Virus Res. 2020;286:198103.
    PubMed         Abstract available

  114. PAN X, Dong L, Yang L, Chen D, et al
    Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.
    Virus Res. 2020;286:198057.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: